Clin2
NCT07703735Likely a fitEnrolling by invitation

Survival after ABO-mismatch living donor liver transplant for liver cancer

Liver TransplantationHepatocellular Carcinoma (HCC)

Part of Cancer, Digestive system clinical trials.

This trial looks at how well patients with liver cancer do after receiving a living donor liver transplant that is not the same blood type. It compares survival and cancer return for these patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
371 people
Ages
18 years and older
Study type
Observational

Who can take part

  • Must be 18 years or older
  • Had a living donor liver transplant for liver cancer
  • Transplant happened between January 2012 and December 2023

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06539377Not yet recruiting
Living donor liver transplant for bile duct cancer

This trial tests whether a living donor liver transplant can help people with a certain type of liver cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. It is for patients whose cancer has not spread and who have responded well to chemotherapy.

NCT07629193Not yet recruiting
Liver transplant for liver cancer

This study looks back at patients who had a liver transplant for hepatocellular carcinoma (a type of liver cancer) between 2018 and 2023. It aims to learn more about their outcomes and experiences.

NCT04622540Recruiting
Study for living donor liver transplant patients

This study looks at living donor liver transplant care and follows patients for about 3 years to see how they do over time. If you had (or are scheduled for) a living donor liver transplant and can be followed long-term, this trial may be able to collect your outcomes.

Seoul
NCT06717919Recruiting· Phase 4
Testing HOPE treatment to prevent liver cancer return after transplant

This study tests a special way of preserving donated livers, called HOPE, to see if it lowers the chance of liver cancer coming back after a liver transplant. If you have liver cancer and are waiting for a transplant, this trial might be an option for you.

New York, New York
NCT07273448Enrolling by invitation
ABO-mismatched living donor liver transplant study

This study looks at the results of liver transplants from living donors with a different blood type than the recipient. It aims to understand how well patients do after this type of transplant.

NCT05951231Not yet recruiting
Liver transplant after preserving a donated liver

This trial tests a new way to preserve donated livers before transplant, which may help people with severe liver disease get a transplant sooner. It may be an option for patients with certain cancers or urgent liver failure.

Hear when a new Liver Transplantation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.